Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors

American Journal of Physiology. Endocrinology and Metabolism
Nacide Ercan-FangFrank Q Nuttall

Abstract

Phosphorylase is regulated by a number of small-molecular-weight effectors that bind to three sites on the enzyme. Recently, a fourth site referred to as the indole-inhibitor site has been identified. Synthetic compounds bind to the site and inhibit activity. However, the effects of these compounds in the presence of other endogenous effectors are unknown. We have determined the effects of four indole derivative glycogen phosphorylase inhibitors (GPI) on recombinant human liver glycogen phosphorylase a activity. The GPIs tested were all potent inhibitors. However, the endogenous inhibitors (glucose, ADP, ATP, fructose 1-phosphate, glucose 6-phosphate, UDP-glucose) and the activator (AMP) markedly reduced the inhibitory effect of GPIs. Consistent with these in vitro findings, the IC50 for the inhibition of glycogenolysis in cells and the liver drug concentration associated with glucose-lowering activity in diabetic ob/ob mice in vivo were also significantly higher than those determined in in vitro enzyme assays. The inhibitory effect of indole-site effectors is modulated by endogenous small-molecular-weight effectors of phosphorylase a activity. However, at higher concentrations (10-30 microM), the GPI effect was dominant and re...Continue Reading

References

Nov 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J SyguschR J Fletterick
Feb 1, 1992·Archives of Biochemistry and Biophysics·S A Westphal, Frank Q Nuttall
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A P KoretskyT Van Dyke
Feb 9, 1990·Molecular and Cellular Biochemistry·W J RoeslerR L Khandelwal
Jan 1, 1989·Critical Reviews in Biochemistry and Molecular Biology·C B NewgardR J Fletterick
Aug 4, 1989·Science·E J GoldsmithR J Fletterick
Jan 1, 1986·Advances in Experimental Medicine and Biology·G Van den Berghe, J Jaeken
Jan 1, 1971·Archives internationales de physiologie et de biochimie·W StalmansH G Hers
May 1, 1972·Analytical Biochemistry·D P GilboeFrank Q Nuttall
Oct 1, 1984·The American Journal of Physiology·C B NiewoehnerFrank Q Nuttall
Jan 1, 1980·Annual Review of Biochemistry·R J Fletterick, N B Madsen
Mar 1, 1981·The Biochemical Journal·G Gevers, W Stalmans
Apr 15, 1996·Archives of Biochemistry and Biophysics·N ErcanFrank Q Nuttall
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·W H MartinJudith L Treadway
Jul 31, 1998·Journal of Medicinal Chemistry·D J HooverJudith L Treadway
Sep 12, 2000·Chemistry & Biology·V L RathD J Hoover
Dec 20, 2000·American Journal of Physiology. Endocrinology and Metabolism·G BodenT P Stein
Feb 13, 2001·American Journal of Physiology. Endocrinology and Metabolism·Nacide Ercan-FangMary C Gannon
Feb 28, 2001·Expert Opinion on Investigational Drugs·Judith L TreadwayD J Hoover
Jun 18, 2002·American Journal of Physiology. Endocrinology and Metabolism·Nacide Ercan-FangFrank Q Nuttall

Related Concepts

glucose-1-phosphate, sodium salt, (D-Glc)-isomer
fructose-1-phosphate, monosodium salt, (D)-isomer
CP 320626
CP 403700
Magnesium ADP
Adenosine Triphosphate, Chromium Ammonium Salt
Amides
Blood Glucose
Dose-Response Relationship, Drug
Enzyme Activation

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.